Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Molins, JB; Jimenez, JGD; Valderrama, BP; Echaburu, JAV; Hernando-Polo, S; Duran, MAC; Villa-Guzman, JC; Arija, JAA; Ostiategui, ML; Milagro, NL; Gonzalez-del-Alba, A; Gonzalez, BM; Diaz, EG; Gauna, DC; Santasusana, MD; Herranz, UA; Solans, XGD; Perez-Gracia, JL; Vazquez, JP; Morales-Barrera, R; Pous, AF.

Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma

CLINICAL GENITOURINARY CANCER. 2020; 18(6): 452-460 Nº de citas: 11 [doi:10.1016/j.clgc.2020.05.004]

Munoz-Unceta, N; Zugazagoitia, J; Manzano, A; Jimenez-Aguilar, E; Olmedo, ME; Cacho, JD; Oliveira, J; Domine, M; Ortega-Moran, L; Aguado, C; Luna, AM; Fernandez, L; Perez, J; Font, C; Salvador, C; Corral, J; Benitez, G; Ros, S; Biosca, M; Calvo, V; Martinez, J; Sanchez-Canovas, M; Lopez, R; Sereno, M; Mielgo, X; Aparisi, F; Carmona, M; Carrion, R; Ponce-Aix, S; Soares, M; Martinez-Salas, I; Garcia-Morillo, M; Juan-Vidal, O; Blasco, A; Munoz, AJ; Paz-Ares, L; Grp Trombosis & Canc SEOM.

High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1

EUROPEAN JOURNAL OF CANCER. 2020; 141: 193-198 Nº de citas: 22 [doi:10.1016/j.ejca.2020.10.002]

Rubio, VEC; Perez-Segura, P; Munoz, A; Farre, AL; Ruiz, LC; Lorente, JA.

High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score

THROMBOSIS RESEARCH. 2020; 196: 349-354 Nº de citas: 26 [doi:10.1016/j.thromres.2020.09.021]

Johnston, SRD; Harbeck, N; Hegg, R; Toi, M; Martin, M; Shao, ZM; Zhang, QY; Rodriguez, JLM; Campone, M; Hamilton, E; Sohn, J; Guarneri, V; Okada, M; Boyle, F; Neven, P; Cortes, J; Huober, J; Wardley, A; Tolaney, SM; Cicin, I; Smith, IC; Frenzel, M; Headley, D; Wei, R; San Antonio, B; Hulstijn, M; Cox, J; O'Shaughnessy, J; Rastogi, P; Behalf MonarchE Comm Members Inve.

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

JOURNAL OF CLINICAL ONCOLOGY. 2020; 38(34): Nº de citas: 698 [doi:10.1200/JCO.20.02514]

Gonzalez-del-Alba, A; Arranz, JA; Bellmunt, J; Maroto, JP; Fernandez-Calvo, O; Valderrama, BP; Gonzalez-Billalabeitia, E; Mendez-Vidal, MJ; Cassinello, J; Romero-Laorden, N; Climent, MA; Puentel, J; Pelaez, I; Lazaro-Quintela, M; Gallardo, E; Suarez, C.

Latest progress in molecular biology and treatment in genitourinary tumours

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(12): 2175-2195 [doi:10.1007/s12094-020-02373-z]

Cabezon-Gutierrez, L; Custodio-Cabello, S; Palka-Kotlowska, M; Oliveros-Acebes, E; Garcia-Navarro, MJ; Khosravi-Shahi, P.

Seroprevalence of SARS-CoV-2-specific antibodies in cancer outpatients in Madrid (Spain): A single center, prospective, cohort study and a review of available data

CANCER TREATMENT REVIEWS. 2020; 90: Nº de citas: 21 [doi:10.1016/j.ctrv.2020.102102]

Ascierto, PA; Del Vecchio, M; Mandala, M; Gogas, H; Arance, AM; Dalle, S; Cowey, CL; Schenker, M; Grob, JJ; Chiarion-Sileni, V; Marquez-Rodas, I; Butler, MO; Maio, M; Middleton, MR; de la Cruz-Merino, L; Arenberger, P; Atkinson, V; Hill, A; Fecher, LA; Millward, M; Khushalani, NI; Queirolo, P; Lobo, M; de Pril, V; Loffredo, J; Larkin, J; Weber, J.

Adjuvant nivolumab versus ipilimumab in resected stage IIIB-C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial

LANCET ONCOLOGY. 2020; 21(11): 1465-1477 Nº de citas: 414 [doi:10.1016/S1470-2045(20)30494-0]

Litton, JK; Hurvitz, SA; Mina, LA; Rugo, HS; Lee, KH; Goncalves, A; Diab, S; Woodward, N; Goodwin, A; Yerushalmi, R; Roch, H; Im, YH; Eiermann, W; Quek, RGW; Usari, T; Lanzalone, S; Czibere, A; Blum, JL; Martin, M; Ettl, J.

Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial

ANNALS OF ONCOLOGY. 2020; 31(11): 1526-1535 Nº de citas: 286 [doi:10.1016/j.annonc.2020.08.2098]

Michielin, O; van Akkooi, A; Lorigan, P; Ascierto, PA; Dummer, R; Robert, C; Arance, A; Blank, CU; Sileni, VC; Donia, M; Faries, MB; Gaudy-Marqueste, C; Gogas, H; Grob, JJ; Guckenberger, M; Haanen, J; Hayes, AJ; Hoeller, C; Lebbe, C; Lugowska, I; Mandala, M; Marquez-Rodas, I; Nathan, P; Neyns, B; Bagge, RO; Puig, S; Rutkowski, P; Schilling, B; Sondak, VK; Tawbi, H; Testori, A; Keilholz, U.

ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee

ANNALS OF ONCOLOGY. 2020; 31(11): 1449-1461 Nº de citas: 95 [doi:10.1016/j.annonc.2020.07.005]

Keilholz, U; Ascierto, PA; Dummer, R; Robert, C; Lorigan, P; van Akkooi, A; Arance, A; Blank, CU; Sileni, VC; Donia, M; Faries, MB; Gaudy-Marqueste, C; Gogas, H; Grob, JJ; Guckenberger, M; Haanen, J; Hayes, AJ; Hoeller, C; Lebbe, C; Lugowska, I; Mandala, M; Marquez-Rodas, I; Nathan, P; Neyns, B; Bagge, RO; Puig, S; Rutkowski, P; Schilling, B; Sondak, VK; Tawbi, H; Testori, A; Michielin, O.

ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee

ANNALS OF ONCOLOGY. 2020; 31(11): 1435-1448 Nº de citas: 158 [doi:10.1016/j.annonc.2020.07.004]

Cabezon-Gutierrez, L; Custodio-Cabello, S; Palka-Kotlowska, M; Khosravi-Shahi, P.

High-Dose 8% Capsaicin Patch in Treatment of Chemotherapy-Induced Peripheral Neuropathy. A Systematic Review

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT. 2020; 60(5): 1047 Nº de citas: 8 [doi:10.1016/j.jpainsymman.2020.06.026]

Metro, G; Banna, GL; Signorelli, D; Gili, A; Galetta, D; Galli, G; Economopoulou, P; Roila, F; Friedlaender, A; Camerini, A; Christopoulou, A; Cantale, O; De Toma, A; Pizzutilo, P; Jimenez, B; Collazo-Lorduy, A; Calles, A; Baxevanos, P; Linardou, H; Kosmidis, P; Giannarelli, D; Mountzios, G; Addeo, A.

Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced Non-Small Cell Lung Cancer With a PD-L1 Expression >= 50%

JOURNAL OF IMMUNOTHERAPY. 2020; 43(9): 299-306 Nº de citas: 24 [doi:10.1097/CJI.0000000000000340]

Martin, M; Garcia-Saenz, JA; Manso, L; Llombart, A; Cassinello, A; Atienza, M; Ringeisen, F; Ciruelos, E.

Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer

Future Oncology. 2020; 16(33): 2763-2778 Nº de citas: 11 [doi:10.2217/fon-2020-0604]

Garcia-Alfonso, P; Garcia-Carbonero, R; Garcia-Foncillas, J; Perez-Segura, P; Salazar, R; Vera, R; Cajal, SRY; Hernandez-Losa, J; Landolfi, S; Musulen, E; Cuatrecasas, M; Navarro, S.

Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(11): 1976-1991 Nº de citas: 12 [doi:10.1007/s12094-020-02357-z]

Moran, LO; Alfonso, PG; Caballero, IA; Garcia, BM; Anula, VT; Carmena, MD; Alsar, JS; Alonso, NG; Beranek, MB; Jimenez, MM; Martin, AJM.

Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(11): 2026-2031 Nº de citas: 9 [doi:10.1007/s12094-020-02339-1]

Marquez-Rodas, I; Longo, F; Rodriguez-Ruiz, ME; Calles, A; Ponce, S; Jove, M; Rubio-Viqueira, B; Perez-Gracia, JL; Gomez-Rueda, A; Lopez-Tarruella, S; Ponz-Sarvise, M; Alvarez, R; Soria-Rivas, A; de Miguel, E; Ramos-Medina, R; Castanon, E; Gajate, P; Sempere-Ortega, C; Jimenez-Aguilar, E; Aznar, MA; Calvo, A; Lopez-Casas, PP; Martin-Algarra, S; Martin, M; Tersago, D; Quintero, M; Melero, I.

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors

Science Translational Medicine. 2020; 12(565): Nº de citas: 64 [doi:10.1126/scitranslmed.abb0391]

Lope, V; Guerrero-Zotano, A; Casas, A; Baena-Canada, JM; Bermejo, B; Perez-Gomez, B; Criado-Navarro, I; Antolin, S; Sanchez-Rovira, P; Ramos-Vazquez, M; Anton, A; Castello, A; Garcia-Saenz, JA; Munoz, M; de Juan, A; Andres, R; Llombart-Cussac, A; Hernando, B; Franquesa, RM; Caballero, R; Priego-Capote, F; Martin, M; Pollan, M.

Serum Phospholipids Fatty Acids and Breast Cancer Risk by Pathological Subtype

Nutrients. 2020; 12(10): Nº de citas: 10 [doi:10.3390/nu12103132]

Pollan, M; Casla-Barrio, S; Alfaro, J; Esteban, C; Segui-Palmer, MA; Lucia, A; Martin, M.

Exercise and cancer: a position statement from the Spanish Society of Medical Oncology

CLINICAL & TRANSLATIONAL ONCOLOGY. 2020; 22(10): 1710-1729 Nº de citas: 54 [doi:10.1007/s12094-020-02312-y]